Photo of Christopher Martin

Christopher Martin

Dr

  • 5 WEST 2.49B

20122017

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research interests

I qualified as a Pharmacist in 2008 following my pre-registration training year at the Royal Devon and Exeter NHS Foundation Trust.  I then completed my PhD studies at the Cardiff School of Pharmacy and Pharmaceutical Sciences (CSPPS) investigating novel biodegradable microneedle devices. This work was funded entirely by the company 3M and therefore had a strong commercial emphasis. The research presented a unique challenge, but as a Pharmacist I enjoyed the dual aspects of investigating the underpinning pharmaceutical science combined with a clinically focussed endpoint. I also continued to locum as a community Pharmacist whilst completing my studies.  

Following my PhD I have undertaken a number of research related roles. These have included part-time Research Associate posts at CSPPS and St Mary’s Pharmaceutical Unit, Cardiff and a part-time Research Pharmacist role at Viridian Pharma Ltd. I now feel that I have a breadth of Pharmacy experience encompassing all sectors of the profession from laboratory science to regulatory affairs and the sale and supply of medicines to the general public.

My passion is the design and development of new dosage forms to provide patient preferred therapies that will ultimately improve health outcomes.

As a Teaching Fellow in Pharmaceutics my aim is to convey my enthusiasm for the pharmaceutical sciences to future Pharmacists and to contextualise their learning within the scope of a profession that is becoming increasingly clinical in its focus.

Fingerprint Dive into the research topics where Christopher Martin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Development and Evaluation of Topical Gabapentin Formulations

Martin, C. J., Alcock, N., Hiom, S. & Birchall, J. C., 30 Aug 2017, In : Pharmaceutics. 9, 3

Research output: Contribution to journalArticle

Open Access
4 Citations (Scopus)

Design and In Vitro Interference Test of Microwave Noninvasive Blood Glucose Monitoring Sensor

Choi, H., Naylon, J., Luzio, S., Beutler, J., Birchall, J., Martin, C., Porch, A. & Martin, C., 3 Sep 2015, In : IEEE Transactions on Microwave Theory and Techniques. 63, 10, p. 3016-3025

Research output: Contribution to journalArticle

Open Access
File
  • 76 Citations (Scopus)
    132 Downloads (Pure)

    Severe postherpetic neuralgia and other neuropathic pain syndromes alleviated by topical gabapentin

    Hiom, S., Patel, G. K., Newcombe, R. G., Khot, S. & Martin, C., Jul 2015, In : British Journal of Dermatology. 173, 1, p. 300-2 3 p.

    Research output: Contribution to journalArticle

    14 Citations (Scopus)

    Topical delivery of gabapentin (Gaba Gel™) for neuropathic pain: A 'proof of concept' study

    Hiom, S., Khot, S., Mogford, S., Hart, C., Patel, G., Roberts, G., Martin, C. & Newcombe, R., 1 Oct 2015, In : International Journal of Pharmacy Practice. 23, S2, p. 46 1 p.

    Research output: Contribution to journalArticle

  • Low temperature fabrication of biodegradable sugar glass microneedles for transdermal drug delivery applications

    Martin, C. J., Allender, C. J., Brain, K. R., Morrissey, A. & Birchall, J. C., 28 Feb 2012, In : Journal of Controlled Release. 158, 1, p. 93-101 9 p.

    Research output: Contribution to journalArticle

  • 72 Citations (Scopus)